Click for best price
Late Stage Chronic Kidney Disease Drugs Market Size, Share 2023
Late stage chronic kidney disease therapeutics can be defined as the drugs which are used for the treatment of late-stage CKD - Induced, Hyperphosphatemia, Hyperparathyroidism and Hyperkalemia.
This report aims to provide a comprehensive presentation of the global market for Late Stage Chronic Kidney Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Late Stage Chronic Kidney Disease Drugs. This report contains market size and forecasts of Late Stage Chronic Kidney Disease Drugs in global, including the following market information:
Global Late Stage Chronic Kidney Disease Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Late Stage Chronic Kidney Disease Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Calcimimetics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Late Stage Chronic Kidney Disease Drugs include AbbVie, Amgen, Ardelyx, AstraZeneca, Deltanoid, Akebia Therapeutics, Kyowa Hakko Kirin, OPKO Health and Vifor Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Late Stage Chronic Kidney Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Late Stage Chronic Kidney Disease Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Late Stage Chronic Kidney Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Calcimimetics
Vitamin D Sterols
Potassium Binders
Others
Global Late Stage Chronic Kidney Disease Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Late Stage Chronic Kidney Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharnacies
Retail Pharmacies
Global Late Stage Chronic Kidney Disease Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Late Stage Chronic Kidney Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Late Stage Chronic Kidney Disease Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Late Stage Chronic Kidney Disease Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Ardelyx
AstraZeneca
Deltanoid
Akebia Therapeutics
Kyowa Hakko Kirin
OPKO Health
Vifor Pharma
Sanofi
Shield Therapeutics
Shire
Spectrum
ZS Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Late Stage Chronic Kidney Disease Drugs, market overview.
Chapter 2: Global Late Stage Chronic Kidney Disease Drugs market size in revenue.
Chapter 3: Detailed analysis of Late Stage Chronic Kidney Disease Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Late Stage Chronic Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Late Stage Chronic Kidney Disease Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Late Stage Chronic Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Late Stage Chronic Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Late Stage Chronic Kidney Disease Drugs Overall Market Size
2.1 Global Late Stage Chronic Kidney Disease Drugs Market Size: 2022 VS 2030
2.2 Global Late Stage Chronic Kidney Disease Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Late Stage Chronic Kidney Disease Drugs Players in Global Market
3.2 Top Global Late Stage Chronic Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Late Stage Chronic Kidney Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Late Stage Chronic Kidney Disease Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Late Stage Chronic Kidney Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Late Stage Chronic Kidney Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Late Stage Chronic Kidney Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Late Stage Chronic Kidney Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Late Stage Chronic Kidney Disease Drugs Market Size Markets, 2022 & 2030
4.1.2 Calcimimetics
4.1.3 Vitamin D Sterols
4.1.4 Potassium Binders
4.1.5 Others
4.2 By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue, 2024-2030
4.2.3 By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Late Stage Chronic Kidney Disease Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Online Pharnacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue, 2024-2030
5.2.3 By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Late Stage Chronic Kidney Disease Drugs Market Size, 2022 & 2030
6.2 By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue, 2024-2030
6.2.3 By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2030
6.3.2 US Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.3.3 Canada Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.3.4 Mexico Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2030
6.4.2 Germany Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.3 France Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.4 U.K. Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.5 Italy Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.6 Russia Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.8 Benelux Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2030
6.5.2 China Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.3 Japan Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.4 South Korea Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.6 India Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2030
6.6.2 Brazil Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6.3 Argentina Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2030
6.7.2 Turkey Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.7.3 Israel Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
6.7.5 UAE Late Stage Chronic Kidney Disease Drugs Market Size, 2018-2030
7 Late Stage Chronic Kidney Disease Drugs Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.1.4 AbbVie Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.2.4 Amgen Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Ardelyx
7.3.1 Ardelyx Company Summary
7.3.2 Ardelyx Business Overview
7.3.3 Ardelyx Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.3.4 Ardelyx Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.3.5 Ardelyx Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.4.4 AstraZeneca Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Deltanoid
7.5.1 Deltanoid Company Summary
7.5.2 Deltanoid Business Overview
7.5.3 Deltanoid Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.5.4 Deltanoid Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.5.5 Deltanoid Key News & Latest Developments
7.6 Akebia Therapeutics
7.6.1 Akebia Therapeutics Company Summary
7.6.2 Akebia Therapeutics Business Overview
7.6.3 Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.6.4 Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.6.5 Akebia Therapeutics Key News & Latest Developments
7.7 Kyowa Hakko Kirin
7.7.1 Kyowa Hakko Kirin Company Summary
7.7.2 Kyowa Hakko Kirin Business Overview
7.7.3 Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.7.4 Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.7.5 Kyowa Hakko Kirin Key News & Latest Developments
7.8 OPKO Health
7.8.1 OPKO Health Company Summary
7.8.2 OPKO Health Business Overview
7.8.3 OPKO Health Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.8.4 OPKO Health Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.8.5 OPKO Health Key News & Latest Developments
7.9 Vifor Pharma
7.9.1 Vifor Pharma Company Summary
7.9.2 Vifor Pharma Business Overview
7.9.3 Vifor Pharma Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.9.4 Vifor Pharma Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.9.5 Vifor Pharma Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.10.4 Sanofi Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Shield Therapeutics
7.11.1 Shield Therapeutics Company Summary
7.11.2 Shield Therapeutics Business Overview
7.11.3 Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.11.4 Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.11.5 Shield Therapeutics Key News & Latest Developments
7.12 Shire
7.12.1 Shire Company Summary
7.12.2 Shire Business Overview
7.12.3 Shire Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.12.4 Shire Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.12.5 Shire Key News & Latest Developments
7.13 Spectrum
7.13.1 Spectrum Company Summary
7.13.2 Spectrum Business Overview
7.13.3 Spectrum Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.13.4 Spectrum Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.13.5 Spectrum Key News & Latest Developments
7.14 ZS Pharma
7.14.1 ZS Pharma Company Summary
7.14.2 ZS Pharma Business Overview
7.14.3 ZS Pharma Late Stage Chronic Kidney Disease Drugs Major Product Offerings
7.14.4 ZS Pharma Late Stage Chronic Kidney Disease Drugs Revenue in Global Market (2018-2023)
7.14.5 ZS Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Late Stage Chronic Kidney Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Late Stage Chronic Kidney Disease Drugs Market Drivers in Global Market
Table 3. Late Stage Chronic Kidney Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Late Stage Chronic Kidney Disease Drugs in Global Market
Table 5. Top Late Stage Chronic Kidney Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Late Stage Chronic Kidney Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Late Stage Chronic Kidney Disease Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Late Stage Chronic Kidney Disease Drugs Product Type
Table 9. List of Global Tier 1 Late Stage Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Late Stage Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 32. AbbVie Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 36. Amgen Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Ardelyx Company Summary
Table 39. Ardelyx Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 40. Ardelyx Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Ardelyx Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 44. AstraZeneca Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Deltanoid Company Summary
Table 47. Deltanoid Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 48. Deltanoid Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Deltanoid Key News & Latest Developments
Table 50. Akebia Therapeutics Company Summary
Table 51. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 52. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Akebia Therapeutics Key News & Latest Developments
Table 54. Kyowa Hakko Kirin Company Summary
Table 55. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 56. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Kyowa Hakko Kirin Key News & Latest Developments
Table 58. OPKO Health Company Summary
Table 59. OPKO Health Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 60. OPKO Health Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. OPKO Health Key News & Latest Developments
Table 62. Vifor Pharma Company Summary
Table 63. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 64. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Vifor Pharma Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 68. Sanofi Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Shield Therapeutics Company Summary
Table 71. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 72. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Shield Therapeutics Key News & Latest Developments
Table 74. Shire Company Summary
Table 75. Shire Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 76. Shire Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Shire Key News & Latest Developments
Table 78. Spectrum Company Summary
Table 79. Spectrum Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 80. Spectrum Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Spectrum Key News & Latest Developments
Table 82. ZS Pharma Company Summary
Table 83. ZS Pharma Late Stage Chronic Kidney Disease Drugs Product Offerings
Table 84. ZS Pharma Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. ZS Pharma Key News & Latest Developments
List of Figures
Figure 1. Late Stage Chronic Kidney Disease Drugs Segment by Type in 2022
Figure 2. Late Stage Chronic Kidney Disease Drugs Segment by Application in 2022
Figure 3. Global Late Stage Chronic Kidney Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Late Stage Chronic Kidney Disease Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Late Stage Chronic Kidney Disease Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Late Stage Chronic Kidney Disease Drugs Revenue in 2022
Figure 8. By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 16. US Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 28. China Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. AbbVie Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ardelyx Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Deltanoid Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. OPKO Health Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Shire Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Spectrum Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. ZS Pharma Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
